SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trillium Therapeutics -- Ignore unavailable to you. Want to Upgrade?


To: semi_infinite who wrote (221)10/10/2018 1:16:24 AM
From: Bladerunner17  Read Replies (1) | Respond to of 294
 
Semi_infinite,

That's my thinking, too. Worries about a class effect. Is that possible?

Bladerunner



To: semi_infinite who wrote (221)10/11/2018 10:23:11 AM
From: semi_infinite   Read Replies (1) | Respond to of 294
 
FTSV rebounded to 10/4 pricing. SURF and TRIL laggards suffering the inertia of new lows begetting newer lows. I use momentum and volume indicators as a sign of bottoms and those suggest TRIL is close to (if not at) a bottom and SURF not so. Indicator is useful only for short term (few weeks) decisions since it is based on hourly data.



To: semi_infinite who wrote (221)10/31/2018 6:25:57 PM
From: tuck  Read Replies (1) | Respond to of 294
 
FTSV CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Cheers, Tuck